Discover Tenders by Pharmaceutical Glassware Sector

Find the most relevant tenders for Pharmaceutical Glassware. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Pharmaceutical Glassware tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Pharmaceutical Glassware tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Tacrolimus Atc L04Ad02 Obo For The Period 01 09 2024 31 08 2025 Plus Extension Option 1X12 Months

Deadline: 05 Jul 2026

Germany

Ref. No.: 7191811

EMD:Ref Document

Bid Value: Ref Document

414 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Olopatadine Atc S01Gx09 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7190250

EMD:Ref Document

Bid Value: Ref Document

414 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Febuxostat Atc Code According To Who M04Aa03

Deadline: 30 Sep 2026

Germany

Ref. No.: 7189556

EMD:Ref Document

Bid Value: Ref Document

501 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Chlorthalidone Atc C03Ba04 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7189539

EMD:Ref Document

Bid Value: Ref Document

414 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Rasagiline Atc Code According To Who N04Bd02

Deadline: 30 Sep 2025

Germany

Ref. No.: 7188536

EMD:Ref Document

Bid Value: Ref Document

136 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Capsaicin Atc N01Bx04 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7186844

EMD:Ref Document

Bid Value: Ref Document

414 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Milnacipran Atc N06Ax17 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7175295

EMD:Ref Document

Bid Value: Ref Document

414 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Miglustat Atc Code According To Who A16Ax06

Deadline: 31 Aug 2026

Germany

Ref. No.: 7169020

EMD:Ref Document

Bid Value: Ref Document

471 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Epinephrine Atc Code According To Who C01Ca24 In The Form Of A Pre Fille

Deadline: 30 Sep 2025

Germany

Ref. No.: 7168445

EMD:Ref Document

Bid Value: Ref Document

136 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Emtricitabine Rilpivirine Tenofovir Disoproxil Fumarate Atc J05Ar08 Obo For The Period From 01 09 24 31 08 26

Deadline: 05 Jul 2026

Germany

Ref. No.: 7166995

EMD:Ref Document

Bid Value: Ref Document

414 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 7165971

EMD:Ref Document

Bid Value: Ref Document

593 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Trientine Atc Code According To Who A16Ax12

Deadline: 30 Sep 2025

Germany

Ref. No.: 7165354

EMD:Ref Document

Bid Value: Ref Document

136 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Natalizumab Exclusively In Dafo Injection Solution Atc L04Aa23 Obo For The Period 01 09 24 31 08 26

Deadline: 05 Jul 2026

Germany

Ref. No.: 7164900

EMD:Ref Document

Bid Value: Ref Document

414 Days Left

Open House Original Rebate Agreements 2024 06 Aclidinium Bromide Formoterol Active Ingredient Combination

Deadline: 31 Aug 2026

Germany

Ref. No.: 7154440

EMD:Ref Document

Bid Value: Ref Document

471 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Evolocumab C10Ax13 Within The Framework Of A So Called Open House Model

Deadline: 01 Jul 2026

Germany

Ref. No.: 7110598

EMD:Ref Document

Bid Value: Ref Document

410 Days Left

Showing 9376 to 9390 of 9691 results

Discover Tenders by Pharmaceutical Glassware Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Pharmaceutical Glassware Sector

Filter Your Search

FREE Trial plan for all new users!